Disrupting WISP1 signaling or targeting its upstream regulators could potently suppress GBM growth through inhibition on both GSCs and tumor-supportive M2 TAMs, which may provide an effective therapeutic approach to improve treatment for GBMs and potentially other malignant tumors. Here, CCN4 is linked to neoplasm.